454 related articles for article (PubMed ID: 36821353)
1. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
[TBL] [Abstract][Full Text] [Related]
6. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
8. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
[TBL] [Abstract][Full Text] [Related]
11. [Using artificial intelligence as an initial triage strategy in diabetic retinopathy screening program in China].
Li ZX; Zhang J; Fong N; He MG
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(48):3835-3840. PubMed ID: 33371627
[No Abstract] [Full Text] [Related]
12. Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.
Ming S; Xie K; Lei X; Yang Y; Zhao Z; Li S; Jin X; Lei B
Int Ophthalmol; 2021 Apr; 41(4):1291-1299. PubMed ID: 33389425
[TBL] [Abstract][Full Text] [Related]
13. Cost-Utility Analysis of Screening for Diabetic Retinopathy in China.
Zhang Y; Bai W; Li R; Du Y; Sun R; Li T; Kang H; Yang Z; Tang J; Wang N; Liu H
Health Data Sci; 2022; 2022():9832185. PubMed ID: 38487485
[No Abstract] [Full Text] [Related]
14. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China.
Wu X; Wu Y; Tu Z; Cao Z; Xu M; Xiang Y; Lin D; Jin L; Zhao L; Zhang Y; Liu Y; Yan P; Hu W; Liu J; Liu L; Wang X; Wang R; Chen J; Xiao W; Shang Y; Xie P; Wang D; Zhang X; Dongye M; Wang C; Ting DSW; Liu Y; Pan R; Lin H
Nat Commun; 2024 Apr; 15(1):3650. PubMed ID: 38688925
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
18. Economic Evaluation of Artificial Intelligence Systems Versus Manual Screening for Diabetic Retinopathy in the United States.
Chawla H; Uhr JH; Williams JS; Reinoso MA; Weiss JS
Ophthalmic Surg Lasers Imaging Retina; 2023 May; 54(5):272-280. PubMed ID: 37078827
[TBL] [Abstract][Full Text] [Related]
19. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
Xiao X; Xue L; Ye L; Li H; He Y
BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China.
Shen M; Zou Z; Bao H; Fairley CK; Canfell K; Ong JJ; Hocking J; Chow EPF; Zhuang G; Wang L; Zhang L
Lancet Reg Health West Pac; 2023 May; 34():100726. PubMed ID: 37283979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
